Ayae Nishiyama
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Immune Preconditioning with Oral Quercetin Supplement and COVID-19 mRNA Vaccine Responses: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: The Journal of nutrition
Published: September 01, 2025
Repeated Omicron exposures redirect SARS-CoV-2-specific memory B cell evolution toward the latest variants.
Journal: Science translational medicine
Published: August 21, 2024
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes.
Journal: Science advances
Published: June 14, 2023
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope.
Journal: PLoS pathogens
Published: March 10, 2023
Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses.
Journal: Vaccine
Published: September 02, 2022
SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype.
Journal: iScience
Published: February 16, 2022
SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine.
Journal: Science immunology
Published: February 03, 2022
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine.
Journal: Cell reports. Medicine
Published: October 22, 2021
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.
Journal: Immunity
Published: April 16, 2021
Last Updated: 09/26/2026